MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care
Conditions
- Atrial Fibrillation New Onset
Interventions
- DRUG: Magnesium sulfate and then Digoxin
- DRUG: Amiodarone
Sponsor
Sunnybrook Health Sciences Centre
Collaborators